M. Bogenschutz

Clinical Psychology · 2015–2021

A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom M. Bogenschutz trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Matthew W. Johnson
  2. Roland R. Griffiths
  3. Franz X. Vollenweider
  4. Katherine A. MacLean
  5. Michael Kometer
  6. Robin L. Carhart-Harris
  7. U. McCann

Who trusts M. Bogenschutz overall

  1. Robin L. Carhart-Harris
  2. David E. Nichols
  3. Leor Roseman
  4. David J. Nutt

Papers from M. Bogenschutz's perspective

Ordered by how strongly the researchers M. Bogenschutz trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. (Archives of General Psychiatry)
  2. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (Journal of Psychopharmacology)
  3. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (Psychopharmacology)
  4. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders (Nature Reviews Neuroscience)
  5. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (Proceedings of the National Academy of Sciences of the United States of America)
  6. Pilot Study of the 5-HT2AR Agonist Psilocybin in the Treatment of Tobacco Addiction (Journal of Psychopharmacology)
  7. Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness (Journal of Psychopharmacology)
  8. Motivational Interviewing: Helping People Change
  9. The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs (Frontiers in Human Neuroscience)
  10. Human Hallucinogen Research: Guidelines for Safety (Journal of Psychopharmacology)

Their papers